187 results on '"Matías-Guiu, Jorge"'
Search Results
2. European cross-cultural neuropsychological test battery (CNTB) for the assessment of cognitive impairment in multiple sclerosis: Cognitive phenotyping and classification supported by machine learning techniques
- Author
-
Delgado-Álvarez, Alfonso, Hernández-Lorenzo, Laura, Nielsen, T. Rune, Díez-Cirarda, María, Cuevas, Constanza, Montero-Escribano, Paloma, Delgado-Alonso, Cristina, Valles-Salgado, María, Gil-Moreno, María José, Matias-Guiu, Jorge, and Matias-Guiu, Jordi A
- Published
- 2024
- Full Text
- View/download PDF
3. Cognitive dysfunction characteristics of multiple sclerosis with aging
- Author
-
Vidorreta-Ballesteros, Lucía, Matias-Guiu, Jordi A, Delgado-Álvarez, Alfonso, Delgado-Alonso, Cristina, Valles-Salgado, María, Cuevas, Constanza, Gil-Moreno, María José, García-Ramos, Rocío, Montero-Escribano, Paloma, and Matias-Guiu, Jorge
- Published
- 2024
- Full Text
- View/download PDF
4. Thermosensitive chitosan-based hydrogel: A vehicle for overcoming the limitations of nose-to-brain cell therapy
- Author
-
Ojeda-Hernández, Doddy Denise, Velasco-Lozano, Susana, Fraile, José M., Mateos-Díaz, J.C., Rojo, Francisco J., Benito-Martín, María Soledad, Selma-Calvo, Belén, Fuente-Martín, Sarah de la, García-Martín, Marina, Larriba-González, María Teresa, Hernández-Sapiéns, Mercedes Azucena, Canales-Aguirre, Alejandro A., Matias-Guiu, Jordi A., Matias-Guiu, Jorge, and Gomez-Pinedo, Ulises
- Published
- 2024
- Full Text
- View/download PDF
5. Hippocampal subfield abnormalities and biomarkers of pathologic brain changes: from SARS-CoV-2 acute infection to post-COVID syndrome
- Author
-
Díez-Cirarda, Maria, Yus-Fuertes, Miguel, Sanchez-Sanchez, Rafael, Gonzalez-Rosa, Javier J., Gonzalez-Escamilla, Gabriel, Gil-Martínez, Lidia, Delgado-Alonso, Cristina, Gil-Moreno, Maria Jose, Valles-Salgado, Maria, Cano-Cano, Fatima, Ojeda-Hernandez, Denise, Gomez-Ruiz, Natividad, Oliver-Mas, Silvia, Benito-Martín, María Soledad, Jorquera, Manuela, de la Fuente, Sarah, Polidura, Carmen, Selma-Calvo, Belén, Arrazola, Juan, Matias-Guiu, Jorge, Gomez-Pinedo, Ulises, and Matias-Guiu, Jordi A.
- Published
- 2023
- Full Text
- View/download PDF
6. GA-MADRID: design and validation of a machine learning tool for the diagnosis of Alzheimer’s disease and frontotemporal dementia using genetic algorithms
- Author
-
García-Gutierrez, Fernando, Díaz-Álvarez, Josefa, Matias-Guiu, Jordi A., Pytel, Vanesa, Matías-Guiu, Jorge, Cabrera-Martín, María Nieves, and Ayala, José L.
- Published
- 2022
- Full Text
- View/download PDF
7. Development of criteria for cognitive dysfunction in post-COVID syndrome: the IC-CoDi-COVID approach
- Author
-
Matias-Guiu, Jordi A, Herrera, Elena, González-Nosti, María, Krishnan, Kamini, Delgado-Alonso, Cristina, Díez-Cirarda, María, Yus, Miguel, Martínez-Petit, Álvaro, Pagán, Josué, Matías-Guiu, Jorge, Ayala, José Luis, Busch, Robyn, and Hermann, Bruce P
- Published
- 2023
- Full Text
- View/download PDF
8. Comparison of the Diagnostic Accuracy of Five Cognitive Screening Tests for Diagnosing Mild Cognitive Impairment in Patients Consulting for Memory Loss.
- Author
-
Valles-Salgado, María, Matias-Guiu, Jordi A., Delgado-Álvarez, Alfonso, Delgado-Alonso, Cristina, Gil-Moreno, María José, Valiente-Gordillo, Esther, López-Carbonero, Juan Ignacio, Fernández-Romero, Lucía, Peña-DeDiego, Lidia, Oliver-Mas, Silvia, Matías-Guiu, Jorge, and Diez-Cirarda, Maria
- Subjects
MILD cognitive impairment ,MEDICAL screening ,MINI-Mental State Examination ,MEMORY disorders ,MEMORY loss - Abstract
Objectives: We aimed to evaluate and compare the diagnostic capacity of five cognitive screening tests for the diagnosis of mild cognitive impairment (MCI) in patients consulting by memory loss. Methods: A cross-sectional study involving 140 participants with a mean age of 74.42 ± 7.60 years, 87 (62.14%) women. Patients were classified as MCI or cognitively unimpaired according to a comprehensive neuropsychological battery. The diagnostic properties of the following screening tests were compared: Mini-Mental State Examination (MMSE), Addenbrooke's Cognitive Examination III (ACE-III) and Mini-Addenbrooke (M-ACE), Memory Impairment Screen (MIS), Montreal Cognitive Assessment (MoCA), and Rowland Universal Dementia Assessment Scale (RUDAS). Results: The area under the curve (AUC) was 0.861 for the ACE-III, 0.867 for M-ACE, 0.791 for MoCA, 0.795 for MMSE, 0.731 for RUDAS, and 0.672 for MIS. For the memory components, the AUC was 0.869 for ACE-III, 0.717 for MMSE, 0.755 for MoCA, and 0.720 for RUDAS. Cronbach's alpha was 0.827 for ACE-III, 0.505 for MMSE, 0.896 for MoCA, and 0.721 for RUDAS. Correlations with Free and Cued Selective Reminding Test were moderate with M-ACE, ACE-III, and MoCA, and moderate for the other tests. The M-ACE showed the best balance between diagnostic capacity and time of administration. Conclusions: ACE-III and its brief version M-ACE showed better diagnostic properties for the diagnosis of MCI than the other screening tests. MoCA and MMSE showed adequate properties, while the diagnostic capacity of MIS and RUDAS was limited. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
9. Identification of the main components of spontaneous speech in primary progressive aphasia and their neural underpinnings using multimodal MRI and FDG-PET imaging
- Author
-
Matias-Guiu, Jordi A., Suárez-Coalla, Paz, Yus, Miguel, Pytel, Vanesa, Hernández-Lorenzo, Laura, Delgado-Alonso, Cristina, Delgado-Álvarez, Alfonso, Gómez-Ruiz, Natividad, Polidura, Carmen, Cabrera-Martín, María Nieves, Matías-Guiu, Jorge, and Cuetos, Fernando
- Published
- 2022
- Full Text
- View/download PDF
10. Biocompatibility of ferulic/succinic acid-grafted chitosan hydrogels for implantation after brain injury: A preliminary study
- Author
-
Ojeda-Hernández, Doddy D., Gomez-Pinedo, Ulises, Hernández-Sapiéns, Mercedes A., Canales-Aguirre, Alejandro A., Espinosa-Andrews, Hugo, Matias-Guiu, Jorge, González-García, Yolanda, and Mateos-Díaz, Juan C.
- Published
- 2021
- Full Text
- View/download PDF
11. Reading prosody in the non-fluent and logopenic variants of primary progressive aphasia
- Author
-
Matias-Guiu, Jordi A., Suárez-Coalla, Paz, Pytel, Vanesa, Cabrera-Martín, María Nieves, Moreno-Ramos, Teresa, Delgado-Alonso, Cristina, Delgado-Álvarez, Alfonso, Matías-Guiu, Jorge, and Cuetos, Fernando
- Published
- 2020
- Full Text
- View/download PDF
12. Detection of cerebrospinal fluid biomarkers changes of Alzheimer's disease using a cognitive stress test in persons with subjective cognitive decline and mild cognitive impairment.
- Author
-
Valles-Salgado, Maria, Gil-Moreno, María José, Curiel Cid, Rosie E., Delgado-Álvarez, Alfonso, Ortega-Madueño, Isabel, Delgado-Alonso, Cristina, Palacios-Sarmiento, Marta, López-Carbonero, Juan I., Cárdenas, María Cruz, Matías-Guiu, Jorge, Díez-Cirarda, María, Loewenstein, David A., and Matias-Guiu, Jordi A.
- Subjects
MILD cognitive impairment ,ALZHEIMER'S disease ,COGNITIVE testing ,AMNESTIC mild cognitive impairment ,CEREBROSPINAL fluid ,LEXICAL access - Abstract
Introduction: Timely and accurate diagnosis of the earliest manifestations of Alzheimer's disease (AD) is critically important. Cognitive challenge tests such as the Loewenstein Acevedo Scales for Semantic Interference and Learning (LASSI-L) have shown favorable diagnostic properties in a number of previous investigations using amyloid or FDG PET. However, no studies have examined LASSI-L performance against cerebrospinal fluid biomarkers of AD, which can be affected before the distribution of fibrillar amyloid and other changes that can be observed in brain neuroimaging. Therefore, we aimed to evaluate the relationship between LASSI-L scores and CSF biomarkers and the capacity of the cognitive challenge test to detect the presence of amyloid and tau deposition in patients with subjective cognitive decline and amnestic mild cognitive impairment (MCI). Methods: One hundred and seventy-nine patients consulting for memory loss without functional impairment were enrolled. Patients were examined using comprehensive neuropsychological assessment, the LASSI-L, and cerebrospinal fluid (CSF) biomarkers (Aβ1-42/Aβ1-40 and ptau181). Means comparisons, correlations, effect sizes, and ROC curves were calculated. Results: LASSI-L scores were significantly associated with CSF biomarkers Aβ1-42/Aβ1-40 in patients diagnosed with MCI and subjective cognitive decline, especially those scores evaluating the capacity to recover from proactive semantic interference effects and delayed recall. A logistic regression model for the entire sample including LASSI-L and age showed an accuracy of 0.749 and an area under the curve of 0.785 to detect abnormal amyloid deposition. Conclusion: Our study supports the biological validity of the LASSI-L and its semantic interference paradigm in the context of the early stages of AD. These findings emphasize the utility and the convenience of including sensitive cognitive challenge tests in the assessment of patients with suspicion of early stages of AD. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
13. Machine learning in the clinical and language characterisation of primary progressive aphasia variants
- Author
-
Matias-Guiu, Jordi A., Díaz-Álvarez, Josefa, Cuetos, Fernando, Cabrera-Martín, María Nieves, Segovia-Ríos, Ignacio, Pytel, Vanesa, Moreno-Ramos, Teresa, Carreras, José L., Matías-Guiu, Jorge, and Ayala, José L.
- Published
- 2019
- Full Text
- View/download PDF
14. Evaluation of the Safety and Efficacy of the Therapeutic Potential of Adipose-Derived Stem Cells Injected in the Cerebral Ischemic Penumbra
- Author
-
Gómez-Pinedo, Ulises, Sanchez-Rojas, Leyre, Benito-Martin, María Soledad, Lendinez, Cristina, León-Espinosa, Gonzalo, Rascón-Ramirez, Fernando José, Herrero, Jone, Castro, Begoña, Moreno-Jiménez, Lidia, del Olmo, Maite, Matias-Guiu, Jordi A., Matias-Guiu, Jorge, and Barcia, Juan A.
- Published
- 2018
- Full Text
- View/download PDF
15. Inhibition impairment in frontotemporal dementia, amyotrophic lateral sclerosis, and Alzheimer’s disease: clinical assessment and metabolic correlates
- Author
-
Matías-Guiu, Jordi A., Cabrera-Martín, María Nieves, Valles-Salgado, María, Rognoni, Teresa, Galán, Lucía, Moreno-Ramos, Teresa, Carreras, José Luis, and Matías-Guiu, Jorge
- Published
- 2019
- Full Text
- View/download PDF
16. Inhibition of neurogenesis in a case of Marburg variant multiple sclerosis
- Author
-
Oreja-Guevara, Celia, Gómez-Pinedo, Ulises, García-López, Julia, Sánchez-Sánchez, Rafael, Valverde-Moyano, Roberto, Rabano-Gutierrez, Alberto, Matías-Guiu, Jordi A., González-Suárez, Ines, and Matías-Guiu, Jorge
- Published
- 2017
- Full Text
- View/download PDF
17. Reading difficulties in primary progressive aphasia in a regular language-speaking cohort of patients
- Author
-
Matías-Guiu, Jordi A., Cuetos, Fernando, Cabrera-Martín, María Nieves, Valles-Salgado, María, Moreno-Ramos, Teresa, Carreras, José Luis, and Matías-Guiu, Jorge
- Published
- 2017
- Full Text
- View/download PDF
18. Neural Basis of Cognitive Assessment in Alzheimer Disease, Amnestic Mild Cognitive Impairment, and Subjective Memory Complaints
- Author
-
Matías-Guiu, Jordi A., Cabrera-Martín, María Nieves, Valles-Salgado, María, Pérez-Pérez, Alicia, Rognoni, Teresa, Moreno-Ramos, Teresa, Carreras, José Luis, and Matías-Guiu, Jorge
- Published
- 2017
- Full Text
- View/download PDF
19. Normative Data in Cross-Cultural Neuropsychological Instruments in Spaniards and Colombians Living in Spain.
- Author
-
Delgado-Álvarez, Alfonso, Delgado-Alonso, Cristina, Valles-Salgado, María, Gil-Moreno, María José, Fernández-Romero, Lucía, Matías-Guiu, Jorge, and Matias-Guiu, Jordi A.
- Subjects
REFERENCE values ,EXECUTIVE function ,SPANIARDS ,COLOMBIANS ,NEUROPSYCHOLOGICAL tests - Abstract
Background: Cross-Cultural Dementia Screening (CCD), Rowland Universal Dementia Assessment Scale (RUDAS), and European Cross-cultural Neuropsychological Test Battery (CNTB) are three novel neuropsychological instruments developed from a cross-cultural perspective to reduce the impact of culture in cognitive assessment and improve the assessment in diverse populations. Objective: We aimed to collect and present normative data on these tests in a majority population sample (Spaniards living in Spain) and in a minority population sample (Colombians living in Spain). Methods: CCD, RUDAS, and CNTB were administered to a group of 300 cognitively healthy participants (150 Spaniards and 150 Colombians). Linear regression modeling strategy was used to provide adjusted norms for demographic factors and to explore the influence of these factors on test performance. Results: Most of the CCD and CNTB scores were predicted by age and years of education, with some tests only predicted by age or showing a ceiling effect. The comparison of normative data between the two samples confirmed the favorable cross-cultural properties of these instruments, with only some differences in processing speed and executive functioning scores. Conclusions: Our study finds a comparable influence of demographic factors in both populations on the performance of CCD, RUDAS, and CNTB, confirming their adequate cross-cultural properties. We provide normative data for these tests in Spaniards and Colombians living in Spain. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
20. FDG-PET-based neural correlates of Addenbrooke's cognitive examination III scores in Alzheimer's disease and frontotemporal degeneration.
- Author
-
Nieves Cabrera-Martín, María, Nespral, Pedro, Valles-Salgado, Maria, Bascuñana, Pablo, Delgado-Alonso, Cristina, Delgado-Álvarez, Alfonso, Fernández-Romero, Lucía, Ignacio López-Carbonero, Juan, Díez-Cirarda, María, José Gil-Moreno, María, Matías-Guiu, Jorge, and Matias-Guiu, Jordi A.
- Subjects
ALZHEIMER'S disease ,POSITRON emission tomography ,TEST scoring ,FRONTOTEMPORAL dementia ,NEUROPSYCHOLOGICAL tests - Abstract
Introduction: The Addenbrooke's Cognitive Examination III (ACE-III) is a brief test useful for neuropsychological assessment. Several studies have validated the test for the diagnosis of Alzheimer's disease (AD) and frontotemporal dementia (FTD). In this study, we aimed to examine the metabolic correlates associated with the performance of ACE-III in AD and behavioral variant FTD. Methods: We enrolled 300 participants in a cross-sectional study, including 180 patients with AD, 60 with behavioral FTD (bvFTD), and 60 controls. An 18F-Fluorodeoxyglucose positron emission tomography study was performed in all cases. Correlation between the ACE-III and its domains (attention, memory, fluency, language, and visuospatial) with the brain metabolism was estimated. Results: The ACE-III showed distinct neural correlates in bvFTD and AD, effectively capturing the most relevant regions involved in these disorders. Neural correlates differed for each domain, especially in the case of bvFTD. Lower ACE-III scores were associated with more advanced stages in both disorders. The ACE-III exhibited high discrimination between bvFTD vs. HC, and between AD vs. HC. Additionally, it was sensitive to detect hypometabolism in brain regions associated with bvFTD and AD. Conclusion: Our study contributes to the knowledge of the brain regions associated with ACE-III, thereby facilitating its interpretation, and highlighting its suitability for screening and monitoring. This study provides further validation of ACE-III in the context of AD and FTD. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
21. Validation of the Lille's Apathy Rating Scale in Very Mild to Moderate Dementia
- Author
-
Fernández-Matarrubia, Marta, Matías-Guiu, Jordi A., Moreno-Ramos, Teresa, Valles-Salgado, María, Marcos-Dolado, Alberto, García-Ramos, Rocío, and Matías-Guiu, Jorge
- Published
- 2016
- Full Text
- View/download PDF
22. Abnormal functional connectivity in radiologically isolated syndrome: A resting-state fMRI study.
- Author
-
Benito-León, Julián, del Pino, Ana Belén, Aladro, Yolanda, Cuevas, Constanza, Domingo-Santos, Ángela, Galán Sánchez-Seco, Victoria, Labiano-Fontcuberta, Andrés, Gómez-López, Ana, Salgado-Cámara, Paula, Costa-Frossard, Lucienne, Monreal, Enrique, Sainz de la Maza, Susana, Matías-Guiu, Jordi A, Matías-Guiu, Jorge, Delgado-Álvarez, Alfonso, Montero-Escribano, Paloma, Martínez-Ginés, María Luisa, Higueras, Yolanda, Ayuso-Peralta, Lucía, and Malpica, Norberto
- Subjects
FUNCTIONAL connectivity ,FRONTOPARIETAL network ,FUNCTIONAL magnetic resonance imaging ,DEFAULT mode network ,EXECUTIVE function - Abstract
Background: Radiologically isolated syndrome (RIS) patients might have psychiatric and cognitive deficits, which suggests an involvement of major resting-state functional networks. Notwithstanding, very little is known about the neural networks involved in RIS. Objective: To examine functional connectivity differences between RIS and healthy controls using resting-state functional magnetic resonance imaging (fMRI). Methods: Resting-state fMRI data in 25 RIS patients and 28 healthy controls were analyzed using an independent component analysis; in addition, seed-based correlation analysis was used to obtain more information about specific differences in the functional connectivity of resting-state networks. Participants also underwent neuropsychological testing. Results: RIS patients did not differ from the healthy controls regarding age, sex, and years of education. However, in memory (verbal and visuospatial) and executive functions, RIS patients' cognitive performance was significantly worse than the healthy controls. In addition, fluid intelligence was also affected. Twelve out of 25 (48%) RIS patients failed at least one cognitive test, and six (24.0%) had cognitive impairment. Compared to healthy controls, RIS patients showed higher functional connectivity between the default mode network and the right middle and superior frontal gyri and between the central executive network and the right thalamus (p
FDR < 0.05; corrected). In addition, the seed-based correlation analysis revealed that RIS patients presented higher functional connectivity between the posterior cingulate cortex, an important hub in neural networks, and the right precuneus. Conclusion: RIS patients had abnormal brain connectivity in major resting-state neural networks and worse performance in neurocognitive tests. This entity should be considered not an "incidental finding" but an exclusively non-motor (neurocognitive) variant of multiple sclerosis. [ABSTRACT FROM AUTHOR]- Published
- 2023
- Full Text
- View/download PDF
23. Structural MRI correlates of PASAT performance in multiple sclerosis
- Author
-
Matias-Guiu, Jordi A., Cortés-Martínez, Ana, Montero, Paloma, Pytel, Vanesa, Moreno-Ramos, Teresa, Jorquera, Manuela, Yus, Miguel, Arrazola, Juan, and Matías-Guiu, Jorge
- Published
- 2018
- Full Text
- View/download PDF
24. Treatment of multiple sclerosis with rituximab: A Spanish multicenter experience.
- Author
-
Gascón-Giménez, Francisco, Alcalá, Carmen, Ramió-Torrentà, Lluís, Montero, Paloma, Matías-Guiu, Jorge, Gómez-Estevez, Irene, Oreja-Guevara, Celia, Gil-Perotín, Sara, Blanco, Yolanda, Carcelén, María, Quintanilla-Bordás, Carlos, Costa, Lucienne, Villar, Luisa Maria, Martínez-Rodriguez, Jose Enrique, Domínguez, José Andrés, Calles, Carmen, González, Inés, Sotoca, Javier, Oterino, Agustin, and Lucas-Jimenez, Celia
- Subjects
MULTIPLE sclerosis ,PROGRESSIVE multifocal leukoencephalopathy ,RITUXIMAB ,JOHN Cunningham virus - Abstract
Introduction: Rituximab (RTX) is considered a potential therapeutic option for relapsing-remitting (RRMS) and progressive forms (PMS) of multiple sclerosis (MS). The main objective of this work was to investigate the effectiveness and safety of rituximab in MS. Patients and methods: Observational multicenter study of clinical and radiological effectiveness and safety of rituximab in RRMS and PMS. Results: A total of 479 rituximab-treated patients were included in 12 Spanish centers, 188 RRMS (39.3%) and 291 (60.7%) PMS. Despite standard treatment, the annualized relapse rate (ARR) the year before RTX was 0.63 (SD: 0.8) and 156 patients (41%) had at least one gadolinium-enhanced lesion (GEL) on baseline MRI. Mean EDSS had increased from 4.3 (SD: 1.9) to 4.8 (SD: 1.7) and almost half of the patients (41%) had worsened at least one point. After a median follow-up of 14.2 months (IQR: 6.5-27.2), ARR decreased by 85.7% (p < 0.001) and GEL by 82.9%, from 0.41 to 0.07 (p < 0.001). A significant decrease in EDSS to 4.7 (p = 0.046) was observed after 1 year of treatment and this variable remained stable during the second year of therapy. There was no evidence of disease activity in 68% of patients. Infusion-related symptoms were the most frequent side effect (19.6%) and most were mild. Relevant infections were reported only in 18 patients (including one case of probable progressive multifocal leukoencephalopathy). Conclusion: Rituximab could be an effective and safe treatment in RRMS, including aggressive forms of the disease. Some selected PMS patients could also benefit from this treatment. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
25. In Vitro Effects of Methylprednisolone over Oligodendroglial Cells: Foresight to Future Cell Therapies.
- Author
-
Gómez-Pinedo, Ulises, Matías-Guiu, Jordi A., Ojeda-Hernandez, Denise, de la Fuente-Martin, Sarah, Kamal, Ola Mohamed-Fathy, Benito-Martin, Maria Soledad, Selma-Calvo, Belen, Montero-Escribano, Paloma, and Matías-Guiu, Jorge
- Subjects
CELLULAR therapy ,OLIGODENDROGLIA ,METHYLPREDNISOLONE ,CELL transplantation ,CELL survival - Abstract
The implantation of oligodendrocyte precursor cells may be a useful therapeutic strategy for targeting remyelination. However, it is yet to be established how these cells behave after implantation and whether they retain the capacity to proliferate or differentiate into myelin-forming oligodendrocytes. One essential issue is the creation of administration protocols and determining which factors need to be well established. There is controversy around whether these cells may be implanted simultaneously with corticosteroid treatment, which is widely used in many clinical situations. This study assesses the influence of corticosteroids on the capacity for proliferation and differentiation and the survival of human oligodendroglioma cells. Our findings show that corticosteroids reduce the capacity of these cells to proliferate and to differentiate into oligodendrocytes and decrease cell survival. Thus, their effect does not favour remyelination; this is consistent with the results of studies with rodent cells. In conclusion, protocols for the administration of oligodendrocyte lineage cells with the aim of repopulating oligodendroglial niches or repairing demyelinated axons should not include corticosteroids, given the evidence that the effects of these drugs may undermine the objectives of cell transplantation. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
26. Validation of the European Cross-Cultural Neuropsychological Test Battery (CNTB) for the assessment of mild cognitive impairment due to Alzheimer's disease and Parkinson's disease.
- Author
-
Delgado-Álvarez, Alfonso, Nielsen, Thomas Rune, Delgado-Alonso, Cristina, Valles-Salgado, María, López-Carbonero, Juan I., García-Ramos, Rocío, Gil-Moreno, María José, Díez-Cirarda, María, Matías-Guiu, Jorge, and Matias-Guiu, Jordi A.
- Subjects
COGNITION disorders diagnosis ,DIAGNOSIS of dementia ,KRUSKAL-Wallis Test ,STATISTICS ,ALZHEIMER'S disease ,ANALYSIS of variance ,PREDICTIVE tests ,RESEARCH methodology evaluation ,MANN Whitney U Test ,NEUROPSYCHOLOGICAL tests ,T-test (Statistics) ,PARKINSON'S disease ,DESCRIPTIVE statistics ,ANALYSIS of covariance ,RESEARCH funding ,DATA analysis software ,DATA analysis ,RECEIVER operating characteristic curves ,SENSITIVITY & specificity (Statistics) ,DISEASE complications - Abstract
Background: The Cross-Cultural Neuropsychological Test Battery (CNTB) is a novel test battery specifically designed to reduce the impact of multiculturality in cognitive assessment. Objective: We aimed to validate the CNTB in Spaniards in patients with Alzheimer's disease (AD), including patients at mild cognitive impairment (MCI) and mild dementia stages, and Parkinson's disease with MCI (PD-MCI). Methods: Thirty patients with AD-MCI, 30 with AD-dementia (AD-D), and 30 with PD-MCI were recruited. Each clinical group was compared against a healthy control group (HC) with no differences in sex, age, or years of education. Intergroup comparisons, ROC analysis, and cut-off scores were calculated. Results: AD-MCI scored lower than HC in those subtests associated with episodic memory and verbal fluency. AD-Dalso showed lower scores in executive functions and visuospatial tests. E_ect sizes for all the subtests were large. PD-MCI showed lower performance than HC in memory and executive functions, particularly on error scores, with large effect sizes. Comparing AD-MCI and PD-MCI, AD-MCI had lower memory scores, while PD-MCI showed the worst performance in executive functions. CNTB showed appropriate convergent validity with standardized neuropsychological tests measuring the same cognitive domains. We obtained similar cut-off scores to previous studies performed in other populations. Conclusions: The CNTB showed appropriate diagnostic properties in AD and PD, including those stages with mild cognitive impairment. This supports the utility of the CNTB for the early detection of cognitive impairment in AD and PD. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
27. Amyloid- and FDG-PET imaging in amyotrophic lateral sclerosis
- Author
-
Matías-Guiu, Jordi A., Pytel, Vanesa, Cabrera-Martín, María Nieves, Galán, Lucía, Valles-Salgado, María, Guerrero, Antonio, Moreno-Ramos, Teresa, Matías-Guiu, Jorge, and Carreras, José Luis
- Published
- 2016
- Full Text
- View/download PDF
28. Multi-Disease Validation of the RUDAS for Cognitive Screening in Alzheimer's Disease, Parkinson's Disease, and Multiple Sclerosis.
- Author
-
Delgado-Álvarez, Alfonso, Díez-Cirarda, María, Delgado-Alonso, Cristina, Hernández-Lorenzo, Laura, Cuevas, Constanza, Valles-Salgado, María, Montero-Escribano, Paloma, Gil-Moreno, María José, Matías-Guiu, Jorge, García-Ramos, Rocío, and Matias-Guiu, Jordi A.
- Subjects
ALZHEIMER'S disease ,PARKINSON'S disease ,MULTIPLE sclerosis ,RANDOM forest algorithms ,MEDICAL screening - Abstract
Background: The Rowland Universal Dementia Assessment Scale (RUDAS) is a cognitive test with favorable diagnostic properties for detecting dementia and a low influence of education and cultural biases. Objective: We aimed to validate the RUDAS in people with Alzheimer's disease (AD), Parkinson's disease (PD), and multiple sclerosis (MS). Methods: We enrolled one hundred and fifty participants (60 with AD, 30 with PD, 60 with MS, and 120 healthy controls (HC)). All clinical groups completed a comprehensive neuropsychological battery, RUDAS, and standard cognitive tests of each disorder: MMSE, SCOPA-COG, and Symbol Digit Modalities Test. Intergroup comparisons between clinical groups and HC and ROC curves were estimated. Random Forest algorithms were trained and validated to detect cognitive impairment using RUDAS and rank the most relevant scores. Results: The RUDAS scores were lower in patients with AD, and patients with PD and MS showed cognitive impairment compared to healthy controls. Effect sizes were generally large. The total score was the most discriminative, followed by the memory score. Correlations with standardized neuropsychological tests were moderate to high. Random Forest algorithms obtained accuracies over 80–90% using the RUDAS for diagnosing AD and cognitive impairment associated with PD and MS. Conclusion: Our results suggest the RUDAS is a valid test candidate for multi-disease cognitive screening tool in AD, PD, and MS. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
29. Amyloid and FDG-PET study of logopenic primary progressive aphasia: evidence for the existence of two subtypes
- Author
-
Matías-Guiu, Jordi A., Cabrera-Martín, María Nieves, Moreno-Ramos, Teresa, Valles-Salgado, María, Fernandez-Matarrubia, Marta, Carreras, José Luis, and Matías-Guiu, Jorge
- Published
- 2015
- Full Text
- View/download PDF
30. Visual and statistical analysis of 18F-FDG PET in primary progressive aphasia
- Author
-
Matías-Guiu, Jordi A., Cabrera-Martín, María Nieves, Pérez-Castejón, María Jesús, Moreno-Ramos, Teresa, Rodríguez-Rey, Cristina, García-Ramos, Rocío, Ortega-Candil, Aida, Fernandez-Matarrubia, Marta, Oreja-Guevara, Celia, Matías-Guiu, Jorge, and Carreras, José Luis
- Published
- 2015
- Full Text
- View/download PDF
31. Clinical course of primary progressive aphasia: clinical and FDG-PET patterns
- Author
-
Matias-Guiu, Jordi A., Cabrera-Martín, María Nieves, Moreno-Ramos, Teresa, García-Ramos, Rocío, Porta-Etessam, Jesús, Carreras, José Luis, and Matías-Guiu, Jorge
- Published
- 2015
- Full Text
- View/download PDF
32. Coronary microvascular dysfunction is associated with impaired cognitive function: the Cerebral-Coronary Connection study (C3 study).
- Author
-
Mejia-Renteria, Hernan, Travieso, Alejandro, Matías-Guiu, Jordi A, Yus, Miguel, Espejo-Paeres, Carolina, Finocchiaro, Francesca, Fernández, Sara, Gomez-Escalonilla, Carlos Ignacio, Reneses-Prieto, Blanca, Gómez-Garré, Maria Dulcenombre, Delgado-Alvarez, Alfonso, Bustos, Ana, Isla, Leopoldo Perez de, Diego, Jose Juan Gomez de, Modrego-Martin, Javier, Ortega-Hernandez, Adriana, Papadopoulos, Petros, Arrazola-García, Juan, Matías-Guiu, Jorge, and Escaned, Javier
- Subjects
MICROCIRCULATION disorders ,CEREBRAL small vessel diseases ,MINI-Mental State Examination ,COGNITIVE ability ,TRAIL Making Test ,MAGNETIC resonance imaging - Abstract
Background It remains unknown whether the presence of coronary microcirculatory dysfunction (CMD) correlates with its equivalent condition in the brain, cerebral small vessel disease (CSVD). The cerebral-coronary connection (C3), a prospective blinded study, investigated the prevalence of CMD in patients with coronary artery disease (CAD) and its association with CSVD and cognitive function. Methods and results Patients with documented CAD fulfilling inclusion criteria underwent physiological assessment of epicardial vessels and the microcirculation using intracoronary pressure and Doppler. Coronary microcirculation-related indices included coronary flow reserve (CFR) and hyperaemic microvascular resistance. Brain magnetic resonance imaging, transcranial Doppler (TCD), and neurocognitive examination were performed. Overall, 67 patients were included in the study (mean age 66 years, 73% female). Patients with abnormal CFR (<2.0) (55.2%) showed higher burden of white-matter hyperintensities: 43.2 vs. 20.0% (P = 0.044). After statistical adjustment, low CFR was associated with lower grey matter volume (P = 0.024) and with parameters of white-matter microstructural damage in diffusion-tensor imaging (lower fractional anisotropy and higher mean diffusivity, P = 0.029 and P = 0.032, respectively). Low CFR was associated with higher resistive (P = 0.027) and pulsatility (P = 0.043) values on TCD, and worse neurocognitive test scores (lower mini mental state examination, P = 0.025, and slower Trail Making Test A, P = 0.034). Conclusions Coronary microcirculatory dysfunction is frequent in patients with CAD and correlates with CSVD, abnormal cerebral flow haemodynamics, and significant cognitive impairment. These findings support the hypothesis that microvascular dysfunction in the heart and the brain are part of a single pathological process affecting microcirculation in patients with CAD. Clinical Trial Registration ClinicalTrials.gov NCT04131075. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
33. Validation of the cross-cultural dementia screening test in Alzheimer's disease and Parkinson's disease.
- Author
-
Delgado-Álvarez, Alfonso, Delgado-Alonso, Cristina, Goudsmit, Miriam, García-Ramos, Rocío, Gil-Moreno, María José, Valles-Salgado, María, Díez-Cirarda, María, Zamarrón-Cassinello, María Dolores, Matías-Guiu, Jorge, and Matias-Guiu, Jordi A.
- Subjects
ALZHEIMER'S disease ,PARKINSON'S disease ,MILD cognitive impairment ,MEDICAL screening ,EXECUTIVE function ,DEMENTIA - Abstract
Objective: The Cross-Cultural Dementia (CCD) is a new screening tool to evaluate cognitive impairment based on a cross-cultural perspective to reduce the bias of education, and language and cultural differences. We aimed to evaluate the diagnostic properties of the CCD in Spaniards for the assessment of patients with Alzheimer's disease in mild cognitive impairment (AD-MCI) and mild dementia stages (AD-D) and patients with mild cognitive impairment associated with Parkinson's disease (PD-MCI). Methods: Sixty participants with AD (50% MCI) and thirty with PD-MCI were enrolled. Each clinical group was compared against a healthy control group (HC) with the same number of participants and no significant differences in age, education, and sex. A comprehensive neuropsychological test battery and CCD were completed. Intergroup comparisons, ROC curves, and cut-off scores were calculated for the study of diagnostic properties. Results: Intergroup differences were found in accordance with the cognitive profile of each clinical condition. Memory measures (Objects test) were especially relevant for the classification between AD and HC. Memory and executive function scores (Sun-Moon and Dots tests) were useful in the case of PD-MCI and HC. Furthermore, CCD described differences in executive functions and speed scores comparing AD-MCI and PD-MCI. Correlations between standardized neuropsychological tests and CCD measures supported the convergent validity of the test. Conclusion: CCD showed good discrimination properties and cut-off scores for dementia and extended its application to a sample of prodromal stages of AD and PD with mild cognitive impairment. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
34. Neuropsychological, Metabolic, and Connectivity Underpinnings of Semantic Interference Deficits Using the LASSI-L.
- Author
-
Valles-Salgado, María, Cabrera-Martín, María Nieves, Curiel-Cid, Rosie E., Delgado-Álvarez, Alfonso, Delgado-Alonso, Cristina, Gil-Moreno, María José, Matías-Guiu, Jorge, Loewenstein, David A., and Matias-Guiu, Jordi A.
- Subjects
CINGULATE cortex ,PARIETAL lobe ,MEMORY disorders ,ALZHEIMER'S disease ,BRAIN metabolism ,COMPUTER adaptive testing ,NEUROLINGUISTICS ,ALZHEIMER'S disease diagnosis ,BRAIN ,MAGNETIC resonance imaging ,NEUROPSYCHOLOGICAL tests ,SEMANTICS - Abstract
Background: LASSI-L is a novel neuropsychological test specifically designed for the early diagnosis of Alzheimer's disease (AD) based on semantic interference.Objective: To examine the cognitive and neural underpinnings of the failure to recover from proactive semantic and retroactive semantic interference.Methods: One hundred and fifty-five patients consulting for memory loss were included. Patients underwent neuropsychological assessment, including the LASSI-L, and FDG-PET imaging. They were categorized as subjective memory complaints (SMC) (n=32), pre-mild cognitive impairment (MCI) due to AD (Pre-MCI) (n=39), MCI due to AD (MCI-AD) (n=71), and MCI without evidence of neurodegeneration (MCI-NN) (n=13). Voxel-based brain mapping and metabolic network connectivity analyses were conducted.Results: A significant group effect was found for all the LASSI-L scores. LASSI-L scores measuring failure to recover from proactive semantic interference and retroactive semantic interference were predicted by other neuropsychological tests with a precision of 64.1 and 44.8%. The LASSI-L scores were associated with brain metabolism in the bilateral precuneus, superior, middle and inferior temporal gyri, fusiform, angular, superior and inferior parietal lobule, superior, middle and inferior occipital gyri, lingual gyrus, and posterior cingulate. Connectivity analysis revealed a decrease of node degree and centrality in posterior cingulate in patients showing frPSI.Conclusion: Episodic memory dysfunction and the involvement of the medial temporal lobe, precuneus and posterior cingulate constitute the basis of the failure to recover from proactive semantic interference and retroactive semantic interference. These findings support the role of the LASSI-L in the detection, monitoring and outcome prediction during the early stages of AD. [ABSTRACT FROM AUTHOR]- Published
- 2022
- Full Text
- View/download PDF
35. The Five-Point Test: Normative data for middle-aged and elderly Spaniards.
- Author
-
Matias-Guiu, Jordi A., Pytel, Vanesa, Delgado-Álvarez, Alfonso, Delgado-Alonso, Cristina, Cortés-Martínez, Ana, Fernández-Oliveira, Aníbal, and Matías-Guiu, Jorge
- Abstract
The Five-Point Test (5PT) is a neuropsychological tool for examining design or figural fluency. In this study, we aimed to provide normative data for the 5PT in Spain. Also, we aimed to compare the norms collected in our research with other normative studies from other populations to evaluate a potential cross-cultural application of 5PT. One hundred and ninety-two healthy subjects aged were enrolled. The mean age was 68.48 ± 9.68 years old (range 50–89), and mean years of education were 10.65 ± 5.22. There were 117 (60.9%) women. The overlapping interval strategy was used to maximize the sample size. Age- and education-adjusted scores were estimated using linear regression analysis. Intraclass correlation coefficient was used to calculate agreement with norms from other countries. Age and years of formal education showed moderate correlations with the scores, while the influence of sex was non-significant. Intraclass correlation coefficient (absolute agreement) between Spanish and German norms was 0.956 (95% confidence interval 0.906–0.978). Norms for unique designs at 1, 2, and 3 minutes are provided. Our study confirms the influence of age and education on design fluency and provides normative data for people older than 50 years old. We hypothesize that 5PT might be a useful test in cross-cultural settings. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
36. Fatigue and Cognitive Dysfunction Are Associated with Occupational Status in Post-COVID Syndrome.
- Author
-
Delgado-Alonso, Cristina, Cuevas, Constanza, Oliver-Mas, Silvia, Díez-Cirarda, María, Delgado-Álvarez, Alfonso, Gil-Moreno, María José, Matías-Guiu, Jorge, and Matias-Guiu, Jordi A.
- Published
- 2022
- Full Text
- View/download PDF
37. Nose-to-Brain: The Next Step for Stem Cell and Biomaterial Therapy in Neurological Disorders.
- Author
-
Villar-Gómez, Natalia, Ojeda-Hernandez, Doddy Denise, López-Muguruza, Eneritz, García-Flores, Silvia, Bonel-García, Natalia, Benito-Martín, María Soledad, Selma-Calvo, Belen, Canales-Aguirre, Alejandro Arturo, Mateos-Díaz, Juan Carlos, Montero-Escribano, Paloma, Matias-Guiu, Jordi A., Matías-Guiu, Jorge, and Gómez-Pinedo, Ulises
- Subjects
STEM cell treatment ,NEUROLOGICAL disorders ,PLURIPOTENT stem cells ,IMMUNOMODULATORS ,CELLULAR therapy - Abstract
Neurological disorders are a leading cause of morbidity worldwide, giving rise to a growing need to develop treatments to revert their symptoms. This review highlights the great potential of recent advances in cell therapy for the treatment of neurological disorders. Through the administration of pluripotent or stem cells, this novel therapy may promote neuroprotection, neuroplasticity, and neuroregeneration in lesion areas. The review also addresses the administration of these therapeutic molecules by the intranasal route, a promising, non-conventional route that allows for direct access to the central nervous system without crossing the blood–brain barrier, avoiding potential adverse reactions and enabling the administration of large quantities of therapeutic molecules to the brain. Finally, we focus on the need to use biomaterials, which play an important role as nutrient carriers, scaffolds, and immune modulators in the administration of non-autologous cells. Little research has been conducted into the integration of biomaterials alongside intranasally administered cell therapy, a highly promising approach for the treatment of neurological disorders. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
38. Design and Verbal Fluency in Alzheimer's Disease and Frontotemporal Dementia: Clinical and Metabolic Correlates.
- Author
-
Delgado-Álvarez, Alfonso, Cabrera-Martín, María Nieves, Pytel, Vanesa, Delgado-Alonso, Cristina, Matías-Guiu, Jorge, and Matias-Guiu, Jordi A.
- Subjects
ALZHEIMER'S disease ,FRONTOTEMPORAL dementia ,EXECUTIVE function ,POSITRON emission tomography ,ALZHEIMER'S patients - Abstract
Objective: Cognitive processes underlying verbal and design fluency, and their neural correlates in patients with Alzheimer's disease (AD) and behavioural variant Frontotemporal Dementia (bvFTD) remain unclear. We hypothesised that verbal and design fluency may be associated with distinct neuropsychological processes in AD and FTD, showing different patterns of impairment and neural basis. Methods: We enrolled 142 participants including patients with AD (n = 80, mean age = 74.71), bvFTD (n = 34, mean age = 68.18), and healthy controls (HCs) (n = 28, mean age = 71.14), that underwent cognitive assessment and
18 F-fluorodeoxyglucose positron emission tomography imaging. Results: Semantic and phonemic fluency showed the largest effect sizes between groups, showing lower scores in bvFTD than AD and HCs, and lower scores in AD than HC. Both AD and bvFTD showed a lower number of unique designs in design fluency in comparison to HC. Semantic fluency was correlated with left frontotemporal lobe in AD, and with left frontal, caudate, and thalamus in bvFTD. Percentage of unique designs in design fluency was associated with the metabolism of the bilateral fronto-temporo-parietal cortex in AD, and the bilateral frontal cortex with right predominance in bvFTD. Repetitions in AD were correlated with bilateral frontal, temporal, and parietal lobes, and with left prefrontal cortex in bvFTD. Conclusions: Our findings demonstrate differential underlying cognitive processes in verbal and design fluency in AD and bvFTD. While memory and executive functioning associated with fronto-temporo-parietal regions were key in AD, attention and executive functions correlated with the frontal cortex and played a more significant role in bvFTD during fluency tasks. [ABSTRACT FROM AUTHOR]- Published
- 2022
- Full Text
- View/download PDF
39. Exosomes and Biomaterials: In Search of a New Therapeutic Strategy for Multiple Sclerosis.
- Author
-
Ojeda-Hernández, Doddy Denise, Hernández-Sapiéns, Mercedes A., Reza-Zaldívar, Edwin E., Canales-Aguirre, Alejandro, Matías-Guiu, Jordi A., Matías-Guiu, Jorge, Mateos-Díaz, Juan Carlos, Gómez-Pinedo, Ulises, and Sancho-Bielsa, Francisco
- Abstract
Current efforts to find novel treatments that counteract multiple sclerosis (MS) have pointed toward immunomodulation and remyelination. Currently, cell therapy has shown promising potential to achieve this purpose. However, disadvantages such as poor survival, differentiation, and integration into the target tissue have limited its application. A series of recent studies have focused on the cell secretome, showing it to provide the most benefits of cell therapy. Exosomes are a key component of the cell secretome, participating in the transfer of bioactive molecules. These nano-sized vesicles offer many therapeutical advantages, such as the capacity to cross the blood-brain barrier, an enrichable cargo, and a customizable membrane. Moreover, integrating of biomaterials into exosome therapy could lead to new tissue-specific therapeutic strategies. In this work, the use of exosomes and their integration with biomaterials is presented as a novel strategy in the treatment of MS. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
40. Neural basis of visuospatial tests in behavioral variant frontotemporal dementia.
- Author
-
Delgado-Álvarez, Alfonso, Nieves Cabrera-Martín, María, Valles-Salgado, María, Delgado-Alonso, Cristina, José Gil, María, Díez-Cirarda, María, Matías-Guiu, Jorge, and Matias-Guiu, Jordi A.
- Subjects
BRAIN metabolism ,FRONTAL lobe ,COGNITION ,TASK performance ,BRAIN mapping ,FISHER exact test ,NEUROPSYCHOLOGICAL tests ,T-test (Statistics) ,PEARSON correlation (Statistics) ,VISUAL perception ,DESCRIPTIVE statistics ,CHI-squared test ,DATA analysis software ,FRONTOTEMPORAL dementia - Abstract
Background: Recent models of visuospatial functioning suggest the existence of three main circuits emerging from the dorsal ("where") route: parietoprefrontal pathway, parieto-premotor, and parieto-medial temporal. Neural underpinnings of visuospatial task performance and the sparing of visuospatial functioning in bvFTD are unclear. We hypothesized different neural and cognitive mechanisms in visuospatial tasks performance in bvFTD and AD. Methods: Two hundred and sixteen participants were enrolled for this study: 72 patients with bvFTD dementia and 144 patients with AD. Visual Object and Space Perception Battery Position Discrimination and Number Location (VOSP-PD and VOSP-NL) and Rey-Osterrieth Complex Figure (ROCF) were administered to examine visuospatial functioning, together with a comprehensive neuropsychological battery. FDG-PET was acquired to evaluate brain metabolism. Voxel-based brain mapping analyses were conducted to evaluate the brain regions associated with visuospatial function in bvFTD and AD. Results: Patients with AD performed worst in visuospatial tasks in mild dementia, but not at prodromal stage. Attention and executive functioning tests showed higher correlations in bvFTD than AD with ROCF, but not VOSP subtests. Visuospatial performance in patients with bvFTD was associated with bilateral frontal regions, including the superior and medial frontal gyri, supplementary motor area, insula and middle cingulate gyrus. Conclusion: These findings support the role of prefrontal and premotor regions in visuospatial processing through the connection with the posterior parietal cortex and other posterior cortical regions. Visuospatial deficits should be interpreted with caution in patients with bvFTD, and should not be regarded as hallmarks of posterior cortical dysfunction. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
41. Persistent olfactory dysfunction after COVID‐19 is associated with reduced perfusion in the frontal lobe.
- Author
-
Yus, Miguel, Matias‐Guiu, Jordi A., Gil‐Martínez, Lidia, Gómez‐Ruiz, Natividad, Polidura, Carmen, Jorquera, Manuela, Delgado‐Alonso, Cristina, Díez‐Cirarda, María, Matías‐Guiu, Jorge, and Arrazola, Juan
- Subjects
SMELL disorders ,POST-acute COVID-19 syndrome ,FRONTAL lobe ,PARANASAL sinuses ,COVID-19 ,OLFACTORY cortex - Abstract
Background: Olfactory dysfunction is common during SARS‐CoV‐2 infection. The pathophysiology of the persistence of this symptom and the potential relationship with central nervous system involvement is unknown. Aim of the study: To evaluate the neural correlates of persistent olfactory dysfunction in a series of patients with post‐COVID syndrome. Methods: Eighty‐two patients with post‐COVID syndrome were assessed with the Brief Smell Identification Test and a multimodal MRI study including 3D‐T1, T2‐FLAIR, diffusion‐tensor imaging, and arterial spin labeling. Olfactory and neuroimaging examinations were performed 11.18 ± 3.78 months after the acute infection. Voxel‐based brain mapping analyses were conducted to correlate the olfactory test with brain volumes, white matter microstructure, and brain perfusion. Results: Olfactory dysfunction was associated with lower tissue perfusion in the orbital and medial frontal regions in the arterial spin labeling sequence. Conversely, no statistically significant findings were detected in brain volumes and diffusion‐tensor imaging. Mild changes in paranasal sinuses and nasal cavities were detected in 9.75% of cases, with no association with olfactory deficits. Conclusions: We provide new insights regarding the pathophysiology of persistent olfactory dysfunction after COVID‐19, involving the main brain regions associated with the olfactory system. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
42. Comparison of Expected Outcomes between Patients and Neurologists Using Kano’s Methodology in Symptomatic Migraine Treatment
- Author
-
Matías-Guiu, Jorge, Caloto, M. T., Nocea, G., and Research Group on Migraine Evaluation in Spain (MIGREXX Study)
- Published
- 2012
- Full Text
- View/download PDF
43. The Adult Macaque Spinal Cord Central Canal Zone Contains Proliferative Cells And Closely Resembles The Human
- Author
-
Alfaro-Cervello, Clara, Cebrian-Silla, Arantxa, Soriano-Navarro, Mario, Garcia-Tarraga, Patricia, Matías-Guiu, Jorge, Gomez-Pinedo, Ulises, Molina Aguilar, Pilar, Alvarez-Buylla, Arturo, Luquin, Maria-Rosario, and Garcia-Verdugo, Jose Manuel
- Published
- 2014
- Full Text
- View/download PDF
44. Neuropsychological Predictors of Fatigue in Post-COVID Syndrome.
- Author
-
Matias-Guiu, Jordi A., Delgado-Alonso, Cristina, Díez-Cirarda, María, Martínez-Petit, Álvaro, Oliver-Mas, Silvia, Delgado-Álvarez, Alfonso, Cuevas, Constanza, Valles-Salgado, María, Gil, María José, Yus, Miguel, Gómez-Ruiz, Natividad, Polidura, Carmen, Pagán, Josué, Matías-Guiu, Jorge, and Ayala, José Luis
- Subjects
POST-acute COVID-19 syndrome ,CANCER fatigue ,STROOP effect ,FATIGUE (Physiology) ,NEUROPSYCHOLOGICAL tests ,NEUROLOGICAL disorders - Abstract
Fatigue is one of the most disabling symptoms in several neurological disorders and has an important cognitive component. However, the relationship between self-reported cognitive fatigue and objective cognitive assessment results remains elusive. Patients with post-COVID syndrome often report fatigue and cognitive issues several months after the acute infection. We aimed to develop predictive models of fatigue using neuropsychological assessments to evaluate the relationship between cognitive fatigue and objective neuropsychological assessment results. We conducted a cross-sectional study of 113 patients with post-COVID syndrome, assessing them with the Modified Fatigue Impact Scale (MFIS) and a comprehensive neuropsychological battery including standardized and computerized cognitive tests. Several machine learning algorithms were developed to predict MFIS scores (total score and cognitive fatigue score) based on neuropsychological test scores. MFIS showed moderate correlations only with the Stroop Color–Word Interference Test. Classification models obtained modest F1-scores for classification between fatigue and non-fatigued or between 3 or 4 degrees of fatigue severity. Regression models to estimate the MFIS score did not achieve adequate R
2 metrics. Our study did not find reliable neuropsychological predictors of cognitive fatigue in the post-COVID syndrome. This has important implications for the interpretation of fatigue and cognitive assessment. Specifically, MFIS cognitive domain could not properly capture actual cognitive fatigue. In addition, our findings suggest different pathophysiological mechanisms of fatigue and cognitive dysfunction in post-COVID syndrome. [ABSTRACT FROM AUTHOR]- Published
- 2022
- Full Text
- View/download PDF
45. The Integration of Cell Therapy and Biomaterials as Treatment Strategies for Remyelination.
- Author
-
López-Muguruza, Eneritz, Villar-Gómez, Natalia, Matias-Guiu, Jordi A., Selma-Calvo, Belen, Moreno-Jiménez, Lidia, Sancho-Bielsa, Francisco, Lopez-Carbonero, Juan, Benito-Martín, María Soledad, García-Flores, Silvia, Bonel-García, Natalia, Kamal, Ola Mohamed-Fathy, Ojeda-Hernández, Denise, Matías-Guiu, Jorge, and Gómez-Pinedo, Ulises
- Subjects
OLIGODENDROGLIA ,CELLULAR therapy ,BIOMATERIALS ,CENTRAL nervous system diseases - Abstract
Multiple sclerosis (MS) is a chronic degenerative autoimmune disease of the central nervous system that causes inflammation, demyelinating lesions, and axonal damage and is associated with a high rate of early-onset disability. Disease-modifying therapies are used to mitigate the inflammatory process in MS but do not promote regeneration or remyelination; cell therapy may play an important role in these processes, modulating inflammation and promoting the repopulation of oligodendrocytes, which are responsible for myelin repair. The development of genetic engineering has led to the emergence of stable, biocompatible biomaterials that may promote a favorable environment for exogenous cells. This review summarizes the available evidence about the effects of transplantation of different types of stem cells reported in studies with several animal models of MS and clinical trials in human patients. We also address the advantages of combining cell therapy with biomaterials. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
46. Diagnosis of Alzheimer's disease and behavioural variant frontotemporal dementia with machine learning‐aided neuropsychological assessment using feature engineering and genetic algorithms.
- Author
-
Garcia‐Gutierrez, Fernando, Delgado‐Alvarez, Alfonso, Delgado‐Alonso, Cristina, Díaz‐Álvarez, Josefa, Pytel, Vanesa, Valles‐Salgado, Maria, Gil, María Jose, Hernández‐Lorenzo, Laura, Matías‐Guiu, Jorge, Ayala, José L., and Matias‐Guiu, Jordi A.
- Subjects
FRONTOTEMPORAL dementia ,ALZHEIMER'S disease ,NEUROPSYCHOLOGICAL tests ,GENETIC engineering ,GENETIC algorithms ,FRONTOTEMPORAL lobar degeneration - Abstract
Background: Neuropsychological assessment is considered a valid tool in the diagnosis of neurodegenerative disorders. However, there is an important overlap in cognitive profiles between Alzheimer's disease (AD) and behavioural variant frontotemporal dementia (bvFTD), and the usefulness in diagnosis is uncertain. We aimed to develop machine learning‐based models for the diagnosis using cognitive tests. Methods: Three hundred and twenty‐nine participants (170 AD, 72 bvFTD, 87 healthy control [HC]) were enrolled. Evolutionary algorithms, inspired by the process of natural selection, were applied for both mono‐objective and multi‐objective classification and feature selection. Classical algorithms (NativeBayes, Support Vector Machines, among others) were also used, and a meta‐model strategy. Results: Accuracies for the diagnosis of AD, bvFTD and the differential diagnosis between them were higher than 84%. Algorithms were able to significantly reduce the number of tests and scores needed. Free and Cued Selective Reminding Test, verbal fluency and Addenbrooke's Cognitive Examination were amongst the most meaningful tests. Conclusions: Our study found high levels of accuracy for diagnosis using exclusively neuropsychological tests, which supports the usefulness of cognitive assessment in diagnosis. Machine learning may have a role in improving the interpretation and test selection. Key points: We developed evolutionary algorithms for an automated diagnosis of behavioural variant frontotemporal dementia (bvFTD) and Alzheimer's disease (AD) based on neuropsychological assessment.Accuracies for the diagnosis of AD, bvFTD and the differential diagnosis between them were higher than 84%.Free and Cued Selective Reminding Test, verbal fluency and Addenbrooke's Cognitive Examination were amongst the most relevant tests for diagnosis.Our study emphasises the role of machine learning in optimising the interpretation of neuropsychological assessment, test selection and cut‐off point determination. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
47. Personalized Repetitive Transcranial Magnetic Stimulation for Primary Progressive Aphasia.
- Author
-
Pytel, Vanesa, Cabrera-Martín, María Nieves, Delgado-Álvarez, Alfonso, Ayala, José Luis, Balugo, Paloma, Delgado-Alonso, Cristina, Yus, Miguel, Carreras, María Teresa, Carreras, José Luis, Matías-Guiu, Jorge, Matías-Guiu, Jordi A, Nieves Cabrera-Martín, María, Luis Ayala, José, and Teresa Carreras, María
- Subjects
TRANSCRANIAL magnetic stimulation ,PATIENTS' attitudes ,CAREGIVER attitudes ,BRAIN metabolism ,CINGULATE cortex ,SPEECH apraxia ,PILOT projects ,LANGUAGE & languages ,APHASIA ,TREATMENT effectiveness ,RANDOMIZED controlled trials ,BLIND experiment ,STATISTICAL sampling ,SPEECH ,EMISSION-computed tomography - Abstract
Background: Primary progressive aphasia (PPA) is a neurodegenerative syndrome for which no effective treatment is available.Objective: We aimed to assess the effect of repetitive transcranial magnetic stimulation (rTMS), using personalized targeting.Methods: We conducted a randomized, double-blind, pilot study of patients with PPA receiving rTMS, with a subgroup of patients receiving active- versus control-site rTMS in a cross-over design. Target for active TMS varied among the cases and was determined during a pre-treatment phase from a list of potential regions. The primary outcome was changes in spontaneous speech (word count). Secondary outcomes included changes in other language tasks, global cognition, global impression of change, neuropsychiatric symptoms, and brain metabolism using FDG-PET.Results: Twenty patients with PPA were enrolled (14 with nonfluent and 6 with semantic variant PPA). For statistical analyses, data for the two variants were combined. Compared to the control group (n = 7), the group receiving active-site rTMS (n = 20) showed improvements in spontaneous speech, other language tasks, patient and caregiver global impression of change, apathy, and depression. This group also showed improvement or stabilization of results obtained in the baseline examination. Increased metabolism was observed in several brain regions after the therapy, particularly in the left frontal and parieto-temporal lobes and in the precuneus and posterior cingulate bilaterally.Conclusion: We found an improvement in language, patient and caregiver perception of change, apathy, and depression using high frequency rTMS. The increase of regional brain metabolism suggests enhancement of synaptic activity with the treatment.Trial Registration: NCT03580954 (https://clinicaltrials.gov/ct2/show/NCT03580954). [ABSTRACT FROM AUTHOR]- Published
- 2021
- Full Text
- View/download PDF
48. Spanish Version of the Mini-Linguistic State Examination for the Diagnosis of Primary Progressive Aphasia.
- Author
-
Matias-Guiu, Jordi A., Pytel, Vanesa, Hernández-Lorenzo, Laura, Patel, Nikil, Peterson, Katie A., Matías-Guiu, Jorge, Garrard, Peter, and Cuetos, Fernando
- Subjects
APHASIA ,LANGUAGE disorders ,DIAGNOSIS ,LANGUAGE ability testing ,RANDOM forest algorithms ,COMMUNICATIVE disorders ,SPEECH apraxia ,DIAGNOSIS of aphasia ,RESEARCH ,LINGUISTICS ,CROSS-sectional method ,RESEARCH methodology ,MEDICAL cooperation ,EVALUATION research ,COMPARATIVE studies ,RESEARCH funding ,TRANSLATIONS - Abstract
Background: Primary progressive aphasia (PPA) is a neurodegenerative syndrome with three main clinical variants: non-fluent, semantic, and logopenic. Clinical diagnosis and accurate classification are challenging and often time-consuming. The Mini-Linguistic State Examination (MLSE) has been recently developed as a short language test to specifically assess language in neurodegenerative disorders.Objective: Our aim was to adapt and validate the Spanish version of MLSE for PPA diagnosis.Methods: Cross-sectional study involving 70 patients with PPA and 42 healthy controls evaluated with the MLSE. Patients were independently diagnosed and classified according to comprehensive cognitive evaluation and advanced neuroimaging.Results: Internal consistency was 0.758. The influence of age and education was very low. The area under the curve for discriminating PPA patients and healthy controls was 0.99. Effect sizes were moderate-large for the discrimination between PPA and healthy controls. Motor speech, phonology, and semantic subscores discriminated between the three clinical variants. A random forest classification model obtained an F1-score of 81%for the three PPA variants.Conclusion: Our study provides a brief and useful language test for PPA diagnosis, with excellent properties for both clinical routine assessment and research purposes. [ABSTRACT FROM AUTHOR]- Published
- 2021
- Full Text
- View/download PDF
49. Development, Spanish Normative Data, and Validation of a Social Cognition Battery in Prodromal Alzheimer's Disease and Multiple Sclerosis.
- Author
-
Delgado-Álvarez, Alfonso, Pytel, Vanesa, Delgado-Alonso, Cristina, Olbrich-Guzmán, Carmen María, Cortés-Martínez, Ana, Moreno-Ramos, Teresa, Montero-Escribano, Paloma, Matías-Guiu, Jorge, and Matias-Guiu, Jordi A
- Subjects
SOCIAL perception ,ALZHEIMER'S disease ,MULTIPLE sclerosis ,NEUROPSYCHOLOGICAL tests ,COGNITIVE testing ,INTERGROUP communication - Abstract
Objectives The assessment of social cognition changes may be challenging, especially in the earliest stages of some neurodegenerative diseases. Our objective was to validate a social cognition battery from a multidomain perspective. In this regard, we aimed to adapt several tests, collect normative data, and validate them in prodromal Alzheimer's disease (AD) and multiple sclerosis (MS). Methods A total of 92 healthy controls, 25 prodromal AD, and 39 MS patients were enrolled. Age-, gender-, and education-matched control groups were created for comparisons. Social cognition battery was composed of an emotion-labeling task developed from FACES database, the Story-based Empathy test (SET), the Faux Pas test, and the Interpersonal Reactivity Index. Patients were also evaluated with a comprehensive cognitive battery to evaluate the other cognitive domains. Automatic linear modeling was used to predict each social cognition test's performance using the neuropsychological tests examining other cognitive domains. Results The reliability of the battery was moderate-high. Significant intergroup differences were found with medium-large effect sizes. Moderate correlations were found between social cognition battery and neuropsychological tests. The emotion labeling task and SET showed moderate correlations with age and education, and age, respectively. Regression-based norms were created considering the relevant demographic variables. Linear regression models including other neuropsychological tests explained between 7.7% and 68.8% of the variance of the social cognition tests performance. Conclusions Our study provides a battery for the assessment of social cognition in prodromal AD and MS with Spanish normative data to improve the evaluation in clinical and research settings. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
50. ACE2, TMPRSS2, and Furin variants and SARS‐CoV‐2 infection in Madrid, Spain.
- Author
-
Torre‐Fuentes, Laura, Matías‐Guiu, Jorge, Hernández‐Lorenzo, Laura, Montero‐Escribano, Paloma, Pytel, Vanesa, Porta‐Etessam, Jesús, Gómez‐Pinedo, Ulises, and Matías‐Guiu, Jordi A.
- Subjects
SARS-CoV-2 ,COVID-19 ,INFECTION ,MULTIPLE sclerosis - Abstract
It has been suggested that some individuals may present genetic susceptibility to SARS‐CoV‐2 infection, with particular research interest in variants of the ACE2 and TMPRSS2 genes, involved in viral penetration into cells, in different populations and geographic regions, although insufficient information is currently available. This study addresses the apparently reasonable hypothesis that variants of these genes may modulate viral infectivity, making some individuals more vulnerable than others. Through whole‐exome sequencing, the frequency of exonic variants of the ACE2, TMPRSS2, and Furin genes was analyzed in relation to presence or absence of SARS‐CoV‐2 infection in a familial multiple sclerosis cohort including 120 individuals from Madrid. The ACE2 gene showed a low level of polymorphism, and none variant was significantly associated with SARS‐CoV‐2 infection. These variants have previously been detected in Italy. While TMPRSS2 is highly polymorphic, the variants found do not coincide with those described in other studies, with the exception of rs75603675, which may be associated with SARS‐CoV‐2 infection. The synonymous variants rs61735792 and rs61735794 showed a significant association with infection. Despite the limited number of patients with SARS‐CoV‐2 infection, some variants, especially in TMPRSS2, may be associated with COVID‐19. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.